NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live NextCure, Inc. Common Stock Share Price Chart

O H L

NextCure, Inc. Common Stock Performance Overview

Days Range
$5.87Low
$5.88High

Markets Today

Previous Close$5.67
Open$5.88
Volume7,974
Day's Range$5.87 - $5.88
52W Range$1.55 - $15.74
Market Cap$27.60 M

Historical Performance

1M Returns-14.74
3M Returns+180.69
6M Returns-51.16
1Y Returns+0.24
5Y Returns-93.25
10Y ReturnsNA

NextCure, Inc. Common Stock Fundamentals

Market Cap$27.60 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-1.11
EPS TTM$-10.27
Quarterly Earnings Growth YOYN/A
PB Ratio2.02
EBITDA$-55.43 M
Profit MarginN/A
Market Cap$27.60 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-1.11
EPS TTM$-10.27
Quarterly Earnings Growth YOYN/A
PB Ratio2.02
EBITDA$-55.43 M
Profit MarginN/A

NextCure, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$11.62 M-$27.29 M-$8.95 M-$9.76 M-$10.11 M-$15.09 M
EBITDA -$10.97 M-$26.66 M-$8.41 M-$9.39 M-$9.82 M-$9.74 M
Interest Expense $0$0$0$0$0$0
Depreciation $654.00 K$633.00 K$533.00 K$365.00 K$283.00 K$5.35 M
Income Before Tax -$10.98 M-$26.81 M-$8.62 M-$9.44 M-$9.80 M-$14.89 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$10.98 M-$26.81 M-$8.62 M-$9.44 M-$9.80 M-$14.89 M
Net Profit Margin ------

NextCure, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $28.00 K$2.00 K$3.00 K$4.00 K$4.00 K$4.00 K
Reserve & Surplus -$391.11 M-$417.93 M-$426.53 M-$435.96 M-$445.78 M-$460.67 M
Non-Current Liabilities $5.54 M$5.26 M$4.97 M$4.67 M$4.37 M$4.06 M
Current Liabilities $5.74 M$10.78 M$10.99 M$10.57 M$6.89 M$6.41 M
Total Liabilities $11.28 M$16.04 M$15.97 M$15.24 M$11.26 M$10.47 M
Fixed Assets $4.80 M$4.17 M$3.64 M$3.27 M$2.99 M$283.00 K
Current Assets $58.90 M$40.02 M$32.64 M$43.75 M$31.74 M$22.25 M
Total Assets $67.14 M$47.69 M$39.61 M$50.18 M$37.98 M$22.62 M

NextCure, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$10.98 M-$26.81 M-$8.62 M-$9.44 M-$9.80 M-$14.89 M
Operating Cash Flow -$12.99 M-$22.71 M-$6.27 M-$7.64 M-$13.36 M-$9.71 M
Investing Cash Flow $7.09 M$3.76 M$8.70 M$6.00 M$1.30 M$9.79 M
Financing Cash Flow $0$2.02 M$0$20.29 M$1.25 M$22.00 K
Change in Cash -$5.90 M-$16.93 M$2.43 M$18.66 M-$10.81 M$93.00 K

NextCure, Inc. Common Stock Return Calculator

The NextCure, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$688
Invested Amount$10,000
Est. Returns$-9,312
Invest in USA Stock Today

About NextCure, Inc. Common Stock

NextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies including antibody-drug conjugates. The company's product candidates include NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

FAQs

NextCure, Inc. Common Stock (NXTC) share price as of September 18, 2026 is $5.78. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the NextCure, Inc. Common Stock (NXTC) Share by opening an international trading account with Angel One.
Purchasing NextCure, Inc. Common Stock (NXTC) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying NextCure, Inc. Common Stock (NXTC) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of NextCure, Inc. Common Stock (NXTC) or any other US company shares in Angel One for any dollar amount.
The market capitalization of NextCure, Inc. Common Stock on September 18, 2026, is $27.60 M.
NextCure, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in NextCure, Inc. Common Stock (NXTC) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91